NCT06679387View on ClinicalTrials.gov

"The Effect of Memantine on the Prevention and Amelioration of Paclitaxel-induced Toxicity in Breast Cancer Patients"

PHASE2RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

October 30, 2024

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Interventions
DRUG

Memantine-HCl

Memantine hydrochloride 20 mg once daily for 12 weeks.

DRUG

Placebo Oral Tablet

A once daily matched tablet of placebo for 12 weeks

Trial Locations (1)

Unknown

RECRUITING

Ain shams University Hospitals, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER